MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-03-0015570
Hubris Pharmaceuticals Private Limited - pharma in Coimbatore, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.74 Lakh
▲ 16% YoY
Net loss · FY 2025
₹1.47 Lakh
Net margin -5%
EBITDA · FY 2025
₹54,607
EBITDA margin 1.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹17.37 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Hubris Pharmaceuticals Private Limited
Data last updated:
Hubris Pharmaceuticals Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24230TZ2007PTC013932. Its GSTIN is 33AABCH9213L1ZL (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Nisar Ahamed Zakir Hussain (Managing Director) and Zakir Hussain Sumaiya Parveen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Coimbatore, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.74 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹1.47 Lakh (net margin -5%) and EBITDA of ₹54,607 (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹17.37 Lakh on record.
Hubris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-03-0015570). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hubrishealth.com.
Company details
CIN U24230TZ2007PTC013932
Registration Number 013932
Incorporation Date 14 September 2007
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-03-0015570
Recognitions & Rankings of Hubris Pharmaceuticals
Contact details
Hubris Pharmaceuticals Private Limited's registered office is in Coimbatore, Tamil Nadu. Its website is hubrishealth.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressOpp Dmart 132 B – 2, Bharathi Nagar, Coimbatore, Tamil Nadu, India – 641023
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hubris Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Hubris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hubris Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hubris Pharmaceuticals Private Limited, buy the company report.
Financials of Hubris Pharmaceuticals Private Limited
FY 2025 filings availableHubris Pharmaceuticals Private Limited reported revenue of ₹29.74 Lakh (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹29.74 Lakh ▲ 16%
Net loss · FY 2025
₹1.47 Lakh margin -5%
EBITDA · FY 2025
₹54,607 margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 22%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 106%
3 years · compounded
▼ 37%
5 years · compounded
▲ 8%
Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54,607 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | -5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hubris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hubris Pharmaceuticals Private Limited
Hubris Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nisar Ahamed Zakir Hussain | Managing Director | 14 Sep 2007 | 19 Years 1 Months | Current |
| Zakir Hussain Sumaiya Parveen | Director | 14 Sep 2007 | 19 Years 1 Months | Current |
Auditor
Hubris Pharmaceuticals Private Limited is audited by KALEEM & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KALEEM & CO | FY 2020 | 001665S |
Shareholding
The shareholding of Hubris Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hubris Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.37 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2019 | 100306517 | Others | ₹17.37 Lakh | Open |
To see the full charge records of Hubris Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Hubris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hubris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hubris Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCH9213L1ZL | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hubris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hubris Pharmaceuticals Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Ghani Haroon Basha ceased to be Director on 30 Aug 2019.
AGM
Hubris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hubris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore.
Charges
A charge with Others of Rs. 17.37 Lakh registered on 13 Nov 2019 with Charge ID 100306517 was modified on 04 Jun 2020.
Charges
A charge with Others amounted to Rs. 17.37 Lakh with Charge ID 100306517 was registered on 13 Nov 2019.
Ceased
Ghani Haroon Basha ceased to be Director.
Ceased
Sabjan Nisar Ahamed ceased to be Director.
Ceased
Salam Abdul Kareem ceased to be Director.
Appointed
Nisar Ahamed Zakir Hussain was appointed as Managing Director.
Appointed
Zakir Hussain Sumaiya Parveen was appointed as Director.
Incorporation
14 Sep 2007
Hubris Pharmaceuticals Private Limited was registered on 14 Sep 2007 with Roc Coimbatore & aged 19 years 1 month as per MCA records.
Frequently asked questions
Hubris Pharmaceuticals is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 2007 (19+ years old) and is registered under CIN U24230TZ2007PTC013932.
Hubris Pharmaceuticals has 2 current directors:
- Nisar Ahamed Zakir Hussain - Managing Director
- Zakir Hussain Sumaiya Parveen - Director
The latest financial statements of Hubris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hubris Pharmaceuticals is 33AABCH9213L1ZL, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Hubris Pharmaceuticals is U24230TZ2007PTC013932. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hubris Pharmaceuticals was incorporated on 14 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Coimbatore.
Ghani Haroon Basha ceased to be Director on 30 Aug 2019. Sabjan Nisar Ahamed ceased to be Director on 30 Aug 2019. Salam Abdul Kareem ceased to be Director on 30 Aug 2019. Hubris Pharmaceuticals has 5 board changes on record in total.
Yes, Hubris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-03-0015570).
Hubris Pharmaceuticals can be reached through the website hubrishealth.com. Its registered office is in Coimbatore, Tamil Nadu, India.
The registered office of Hubris Pharmaceuticals is at Opp Dmart 132 B – 2, Bharathi Nagar, Coimbatore, Tamil Nadu, India – 641023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages